NARI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Inari Medical Inc

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.
CEO
Employees
456
Headquarters

News

How should investors view Inari Medical Inc. (NARI)?
Nov 18, 2022 12:32pm

As of Thursday, Inari Medical Inc.’s (NASDAQ:NARI) stock closed at $79.05, down from $82.69 the previous day. While Inari Medical Inc. has underperformed by -4.40%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -12.43%, with highs and lows ranging from $100.00 to $50.50, […]


Source:US Post News
How did Inari Medical Inc. (NARI) fare last session?
Nov 11, 2022 15:16pm

Inari Medical Inc. (NASDAQ:NARI) marked $76.85 per share on Thursday, up from a previous closing price of $69.47. While Inari Medical Inc. has overperformed by 10.62%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -17.36%, with highs and lows ranging from $100.00 to […]


Source:US Post News
Inari Medical, Inc. (NARI) Q3 2022 Earnings Call Transcript
Nov 03, 2022 03:38am

Inari Medical, Inc. (NASDAQ:NASDAQ:NARI) Q3 2022 Earnings Conference Call November 02, 2022 4:30 PM ET Company Participants Caroline Corner – Investor Relations Bill Hoffman – President and…


Source:Seeking Alpha
Inari Medical GAAP EPS of -$0.19 beats by $0.06, revenue of $96.2M beats by $5.37M
Nov 02, 2022 20:12pm

Inari Medical press release (NARI): Q3 GAAP EPS of -$0.19 beats by $0.06.Revenue of $96.2M (+31.9% Y/Y) beats by $5.37M.Full-Year 2022 Revenue GuidanceFor the full year 2022, we…


Source:Seeking Alpha
Inari Medical Reports Third Quarter 2022 Financial Results
Nov 02, 2022 20:05pm

IRVINE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its third quarter ended September 30, 2022.


Source:GlobeNewswire
Inari Medical to Announce Third Quarter 2022 Financial Results
Oct 06, 2022 20:01pm

IRVINE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its third quarter 2022 financial results on Wednesday, November 2, 2022. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.


Source:GlobeNewswire
Berenberg Starts Inari Medical Inc. at Buy
Sep 29, 2022 10:34am

https://www.investing.com/news/pro/berenberg-starts-inari-medical-inc-at-buy-432SI-2901775


Source:Investing.com
Inari Medical Inc. (NASDAQ: NARI) Stock Forecast For 2022: Increases Growth Prospects To $9 Per Share
Sep 28, 2022 14:30pm

In the last trading session, 1.34 million Inari Medical Inc. (NASDAQ:NARI) shares changed hands as the company’s beta touched 0. With the company’s per share price at $69.25 changed hands at $0.5 or 0.73% during last session, the market valuation stood at $3.61B. NARI’s last price was a discount, traded about -44.4% off its 52-week … Inari Medical Inc. (NASDAQ: NARI) Stock Forecast For 2022: Increases Growth Prospects To $9 Per Share Read More »


Source:Marketing Sentinel
Analyst Predictions On Inari Medical Inc.’s (NASDAQ: NARI) Future Growth
Sep 27, 2022 14:30pm

Inari Medical Inc. (NASDAQ:NARI) price closed higher on Monday, September 26, jumping 2.49% above its previous close. A look at the daily price movement shows that the last close reads $67.08, with intraday deals fluctuated between $66.98 and $69.93. The company’s 5Y monthly beta was ticking 1.45. Taking into account the 52-week price action we … Analyst Predictions On Inari Medical Inc.’s (NASDAQ: NARI) Future Growth Read More »


Source:Stocks Register
Investing in Inari Medical Inc. (NARI) might be an excellent idea, but the stock is currently overvalued/undervalued
Sep 27, 2022 14:24pm

Inari Medical Inc. (NASDAQ:NARI) closed Monday at $68.75 per share, up from $67.08 a day earlier. While Inari Medical Inc. has overperformed by 2.49%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NARI fell by -17.53%, with highs and lows ranging from $100.00 to $50.50, whereas […]


Source:US Post News